Effect of polyriboinosinic-polyribocytidylic acid on the metabolism and viability of cells in vitro.
D000650:Amnion; D000818:Animals; D002460:Cell Line; D002478:Cells, Cultured / Q000187:drug effects*; D003228:Conjunctiva; D004247:DNA / Q000096:biosynthesis*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D006367:HeLa Cells / Q000378:metabolism; D006801:Humans; D007739:L Cells / Q000378:metabolism; D007930:Leucine / Q000378:metabolism; D007962:Leukocytes; D008214:Lymphocytes; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D009363:Neoplasm Proteins / Q000096:biosynthesis; D009374:Neoplasms, Experimental / Q000378:metabolism*; D011070:Poly I-C / Q000494:pharmacology*; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis*; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012293:Rifampin / Q000494:pharmacology; D012509:Sarcoma / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D014316:Tritium; D012313:RNA; D004247:DNA; D007930:Leucine; D011070:Poly I-C; D013936:Thymidine; D012293:Rifampin; D014529:Uridine